CA2110260A1 - Derives d'acide pyridonecarboxylique - Google Patents

Derives d'acide pyridonecarboxylique

Info

Publication number
CA2110260A1
CA2110260A1 CA002110260A CA2110260A CA2110260A1 CA 2110260 A1 CA2110260 A1 CA 2110260A1 CA 002110260 A CA002110260 A CA 002110260A CA 2110260 A CA2110260 A CA 2110260A CA 2110260 A1 CA2110260 A1 CA 2110260A1
Authority
CA
Canada
Prior art keywords
diastereomers
mixture
pyridonecarboxylic acid
skeleton
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002110260A
Other languages
English (en)
Other versions
CA2110260C (fr
Inventor
Isao Hayakawa
Youichi Kimura
Hisashi Takahashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Isao Hayakawa
Youichi Kimura
Hisashi Takahashi
Daiichi Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isao Hayakawa, Youichi Kimura, Hisashi Takahashi, Daiichi Pharmaceutical Co., Ltd. filed Critical Isao Hayakawa
Publication of CA2110260A1 publication Critical patent/CA2110260A1/fr
Application granted granted Critical
Publication of CA2110260C publication Critical patent/CA2110260C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Stringed Musical Instruments (AREA)
  • Table Devices Or Equipment (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CA002110260A 1991-05-28 1992-05-27 Derives d'acide pyridonecarboxylique Expired - Fee Related CA2110260C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP22542591 1991-05-28
JPHEI.3-225425 1991-05-28
PCT/JP1992/000687 WO1992021659A1 (fr) 1991-05-28 1992-05-27 Derive d'acide pyridonecarboxylique

Publications (2)

Publication Number Publication Date
CA2110260A1 true CA2110260A1 (fr) 1992-12-10
CA2110260C CA2110260C (fr) 2001-12-04

Family

ID=16829173

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002110260A Expired - Fee Related CA2110260C (fr) 1991-05-28 1992-05-27 Derives d'acide pyridonecarboxylique

Country Status (16)

Country Link
US (1) US5696132A (fr)
EP (1) EP0593766B1 (fr)
JP (1) JP3215500B2 (fr)
KR (1) KR100232937B1 (fr)
AT (1) ATE196135T1 (fr)
AU (1) AU661999B2 (fr)
CA (1) CA2110260C (fr)
DE (1) DE69231422T2 (fr)
DK (1) DK0593766T3 (fr)
ES (1) ES2151488T3 (fr)
FI (1) FI109201B (fr)
GR (1) GR3034966T3 (fr)
NO (1) NO180780C (fr)
RU (1) RU2100351C1 (fr)
TW (1) TW212179B (fr)
WO (1) WO1992021659A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3165742B2 (ja) * 1991-07-16 2001-05-14 中外製薬株式会社 キノロンカルボン酸誘導体の製造方法
NO304832B1 (no) * 1992-05-27 1999-02-22 Ube Industries Aminokinolonderivater samt middel mot HIV
CA2112165C (fr) * 1992-12-25 2003-04-08 Makoto Takemura Derives amine bicycliques
DE4339134A1 (de) * 1993-11-16 1995-05-18 Bayer Ag 1-(2-Fluorcyclopropyl)-chinolon- und -naphthyridoncarbonsäure-Derivate
DE4408212A1 (de) * 1994-03-11 1995-09-14 Bayer Ag 5-Vinyl- und 5-Ethinyl-chinolon- und -naphthyridon-carbonsäuren
DK0807630T3 (da) * 1995-02-02 2003-09-01 Daiichi Seiyaku Co Heterocykliske forbindelser
WO1996024593A1 (fr) 1995-02-07 1996-08-15 Daiichi Pharmaceutical Co., Ltd. Derives spiro heterocycliques
US6121285A (en) 1995-11-22 2000-09-19 Daiichi Pharmaceutical Co., Ltd. Substituted aminocycloalkylpyrrolidine derivatives and cis-substituted aminocycloalkylpyrrolidine derivatives
NZ322202A (en) * 1995-11-22 2000-05-26 Daiichi Pharmaceutical Company Aminocycloalkylpyrrolidine derivatives and salts thereof with antibacterial activity
WO1998024781A1 (fr) * 1996-12-04 1998-06-11 Daiichi Pharmaceutical Co., Ltd. Derives d'aminomethylpyrrolidine substitue
JPH1149698A (ja) 1997-07-31 1999-02-23 Santen Pharmaceut Co Ltd 安定性を向上させたラクトフェリンの水性製剤
JP4820290B2 (ja) 2004-05-13 2011-11-24 第一三共株式会社 置換ピロリジン誘導体
US7563805B2 (en) 2005-05-19 2009-07-21 Daiichi Pharmaceutical Co., Ltd. Tri-, tetra-substituted-3-aminopyrrolidine derivative
US7977346B2 (en) 2006-01-17 2011-07-12 Guoqing Paul Chen Spiro compounds and methods of use
CN105330590B (zh) * 2015-10-15 2018-09-25 广州市朗启医药科技有限责任公司 西他沙星五元环侧链中间体的制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6028978A (ja) * 1983-07-27 1985-02-14 Dainippon Pharmaceut Co Ltd １，８−ナフチリジン誘導体
DE3576335D1 (de) * 1984-12-14 1990-04-12 Daiichi Seiyaku Co Chinolincarbonsaeure-derivate.
DE3509546A1 (de) * 1985-03-16 1986-09-25 Bayer Ag, 5090 Leverkusen 7-amino-1-(subst.cyclopropyl)-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3705621C2 (de) * 1986-02-25 1997-01-09 Otsuka Pharma Co Ltd Heterocyclisch substituierte Chinoloncarbonsäurederivate
DE3702393A1 (de) * 1987-01-28 1988-08-11 Bayer Ag 8-cyano-1-cyclopropyl-1,4-dihydro-4-oxo- 3-chinolincarbonsaeuren, verfahren zu ihrer herstellung und diese enthaltende antibakterielle mittel
US5591744A (en) * 1987-04-16 1997-01-07 Otsuka Pharmaceutical Company, Limited Benzoheterocyclic compounds
US4851418A (en) * 1987-08-21 1989-07-25 Warner-Lambert Company Naphthyridine antibacterial agents containing an α-amino acid in the side chain of the 7-substituent
US4920120A (en) * 1988-01-25 1990-04-24 Warner-Lambert Company Antibacterial agents
MY105136A (en) * 1988-04-27 1994-08-30 Daiichi Seiyaku Co Optically active pyridonecarboxylic acid derivatives.
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
US5057520A (en) * 1989-03-24 1991-10-15 Abbott Laboratories 7-(peptidylpyrolidinyl)naphthyridine antibacterial compounds
EP0390215B1 (fr) * 1989-03-30 1995-06-07 Wakunaga Seiyaku Kabushiki Kaisha Dérivés de quinolone et leurs sels, procédés pour leur préparation et agents antibactériens les contenant
US5140033A (en) * 1989-04-03 1992-08-18 Bayer Aktiengesellschaft Antibacterial 5-alkylquinolonecarboxylic acids
DE3910663A1 (de) * 1989-04-03 1990-10-04 Bayer Ag 5-alkylchinoloncarbonsaeuren
US5252734A (en) * 1989-04-03 1993-10-12 Bayer Aktiengesellschaft Antibacterial 5-alkylquinolonecarboxylic acids
DE3918544A1 (de) * 1989-06-07 1990-12-13 Bayer Ag Verfahren zur herstellung von 7-(3-amino- sowie 3-amino-methyl-1-pyrrolidinyl)-3-chinolon- carbonsaeuren sowie -naphthyridoncarbonsaeuren
MY109714A (en) * 1990-10-18 1997-04-30 Daiichi Seiyaku Co Process for preparing 8-chloroquinolone derivatives
US5072001A (en) * 1990-11-30 1991-12-10 Warner-Lambert Company Certain optically active substituted 3-pyrraidine acetic acid derivatives useful as intermediates
US5137892A (en) * 1990-12-12 1992-08-11 Abbott Laboratories Quinoline, naphthyridine and pyridobenzoxazine derivatives

Also Published As

Publication number Publication date
FI935243A0 (fi) 1993-11-25
KR100232937B1 (ko) 1999-12-01
AU1887292A (en) 1993-01-08
NO180780C (no) 1997-06-18
AU661999B2 (en) 1995-08-17
FI109201B (fi) 2002-06-14
NO934279L (no) 1994-01-28
NO934279D0 (no) 1993-11-26
EP0593766A1 (fr) 1994-04-27
ES2151488T3 (es) 2001-01-01
EP0593766A4 (fr) 1994-12-07
RU2100351C1 (ru) 1997-12-27
FI935243A (fi) 1994-01-11
NO180780B (no) 1997-03-10
CA2110260C (fr) 2001-12-04
TW212179B (fr) 1993-09-01
DE69231422D1 (de) 2000-10-12
EP0593766B1 (fr) 2000-09-06
WO1992021659A1 (fr) 1992-12-10
JP3215500B2 (ja) 2001-10-09
US5696132A (en) 1997-12-09
DK0593766T3 (da) 2000-10-09
GR3034966T3 (en) 2001-02-28
JPH05163244A (ja) 1993-06-29
ATE196135T1 (de) 2000-09-15
DE69231422T2 (de) 2001-03-29

Similar Documents

Publication Publication Date Title
CA2110260A1 (fr) Derives d'acide pyridonecarboxylique
CA2335285A1 (fr) Piperidine bicyclique et composes de piperazine presentant une affinite pour le recepteur 5-ht6
WO1994022835A3 (fr) Composes heterocycliques en tant qu'inhibiteurs de l'agregation plaquettaire
HK1003708A1 (en) Peripheral vasodilating agent containing n-acylated 4-amino piperidine derivatives as active ingredients
GR3014973T3 (en) Use of benzimidazole derivatives as antibacterial agents.
WO2001017972A3 (fr) Nouveaux herbicides
EP0711768A4 (fr) Derive de benzimidazol
CA2195243A1 (fr) Composes triazole et leur utilisation
MX9606331A (es) Nuevos compuestos, procesos para la preparacion de los mismos y agentes antitumor.
DK1063228T5 (da) Cycloalkenderivater, fremgangsmåde til fremstilling deraf og anvendelse deraf
YU76401A (sh) 1-amino triazolo(4,3-a)hinazolin-5-oni i/ili - 5-tioni koji inhibiraju fosfodiesteraze iv
CA2107223A1 (fr) Chlorhydrate de tiagabine monohydrate cristallin, sa preparation et son utilisation
EP1197210A4 (fr) Agents inhibant les reactions de rejet chronique faisant suite a une greffe d'organe
RU93058417A (ru) Производные пиридон-карбоновой кислоты, антимикробный агент
CA2256438A1 (fr) Derives d'amidine aromatique utiles en tant qu'inhibiteurs selectifs de la thrombine
CA2327673A1 (fr) Derives d'aminopiperidine comme antagonistes d'integrine .alpha.v.beta.3
DE69814800T2 (de) Epoxysuccinamid-derivate oder ihre salze
CA2016551A1 (fr) Derives de thieno-triazolo-diazepine, procede de preparation, et composes therapeutiques contenant lesdits derives
EP0546177A4 (fr) Derive de benzopyrane, sa production, et composition pharmaceutique le contenant.
CA2112083A1 (fr) Composes aryliques heterocycliques substitues
CA2112061A1 (fr) Composes alkyliques heterocycliques substitues
CA2108817A1 (fr) Arylidene-1-azacycloalcanes et arylalkyl-1-azacycloalcanes, leurs sels, medicaments qui contiennent de ces composes et leur utilisation, et procedes pour leur obtention
ES2128031T3 (es) Forma cristalina y polimorfica de (s,s,s)-n-(1-(2-carboxi-3-(n2-mesilisilamino)propil)-1-ciclopentilcarbonil)tirosina.
EP0897919A4 (fr) Nouveaux derives de l'acide pyridonocarboxylique ou des sels de cet acide et agents antibacteriens contenant ces substances en tant que composant actif
CA2163778A1 (fr) Derives de l'indole, inhibiteurs de la 5-alpha-reductase steroidienne

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed